Neoadjuvant treatment of renal cell carcinoma

Urologic Oncology
W Kimryn RathmellEric Wallen

Abstract

Renal cell carcinoma is a potentially devastating cancer, and when metastatic, remains incurable with currently available systemic therapy. Surgical nephrectomy remains the only proven modality which can offer curative options for patients with resectable disease. Further, cytoreductive nephrectomy continues to play a role in the metastatic disease setting. The use of targeted therapy as an adjunct to surgical resection is beginning to be explored in both of these clinical scenarios. Immediate questions regarding preoperative treatment with VEGF pathway targeted therapy include issues surrounding the safety of these agents in use in the perioperative time period, the expectations for response in the primary tumor, the optimal duration of therapy, and the clinical settings in which this therapy may be most beneficial. This review will discuss the current experience with neoadjuvant or preoperative therapy in locally advanced or metastatic renal cell carcinoma and will overview the challenges and opportunities which lie ahead for this form of multimodality therapy.

References

May 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert J MotzerVictor Reuter
Jun 18, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joseph I ClarkKim A Margolin
Sep 28, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·James C Yang
Apr 26, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark J RatainPeter J O'Dwyer
Jan 12, 2007·The New England Journal of Medicine·Bernard EscudierUNKNOWN TARGET Study Group
Feb 24, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Brian I Rini
Jan 26, 2008·Cancer Biology & Therapy·Keith T FlahertyPeter J O'Dwyer
Jun 21, 2008·International Urology and Nephrology·Opeyemi A FalebitaHarry Comber

❮ Previous
Next ❯

Citations

Aug 4, 2010·Targeted Oncology·Eric A SingerRamaprasad Srinivasan
Nov 23, 2011·Current Urology Reports·Paul L Crispen, Michael L Blute
Nov 30, 2010·Der Urologe. Ausg. A·M StaehlerC G Stief
May 2, 2012·Journal of Cancer Research and Clinical Oncology·Kwang Hyun KimChoung-Soo Kim
Jul 19, 2011·Hematology/oncology Clinics of North America·Marc C SmaldoneNaomi B Haas
Apr 6, 2011·Orvosi hetilap·Anikó Maráz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.